{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:19:28Z","timestamp":1771953568016,"version":"3.50.1"},"reference-count":23,"publisher":"Zhejiang University Press","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1631\/jzus.b1000230","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T08:58:50Z","timestamp":1309424330000},"page":"568-574","source":"Crossref","is-referenced-by-count":21,"title":["Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity"],"prefix":"10.1631","volume":"12","author":[{"given":"Yun","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"issue":"10","key":"3028_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","volume":"34","author":"X. An","year":"2010","unstructured":"An, X., Tiwari, A.K., Sun, Y., Ding, P.R., 2010. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review. Leuk. Res., 34(10):1255\u20131268. [doi:10.1016\/j.leukres.2010.04.016]","journal-title":"Leuk. Res."},{"issue":"10","key":"3028_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/iub.239","volume":"61","author":"A. Chaudhury","year":"2009","unstructured":"Chaudhury, A., Howe, P.H., 2009. The tale of transforming growth factor-\u03b2 (TGF\u03b2) signaling: a soign\u00e9 enigma. IUBMB Life, 61(10):929\u2013939. [doi:10.1002\/iub.239]","journal-title":"IUBMB Life"},{"issue":"17","key":"3028_CR3","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1073\/pnas.150006697","volume":"97","author":"G.F. Claassen","year":"2000","unstructured":"Claassen, G.F., Hann, S.R., 2000. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor \u03b2-induced cell-cycle arrest. PNAS, 97(17):9498\u20139503. [doi:10.1073\/pnas.150006697]","journal-title":"PNAS"},{"issue":"12","key":"3028_CR4","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","volume":"107","author":"M. Dong","year":"2006","unstructured":"Dong, M., Blobe, G.C., 2006. Role of transforming growth factor-\u03b2 in hematologic malignancies. Blood, 107(12): 4589\u20134596. [doi:10.1182\/blood-2005-10-4169]","journal-title":"Blood"},{"issue":"23","key":"3028_CR5","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"B.J. Druker","year":"2006","unstructured":"Druker, B.J., Guilhot, F., O\u2019Brien, S.G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M.W., Silver, R.T., Goldman, J.M., Stone, R.M., et al., 2006. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med., 355(23):2408\u20132417. [doi:10.1056\/NEJMoa062867]","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"3028_CR6","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","volume":"23","author":"R.L. Elliott","year":"2005","unstructured":"Elliott, R.L., Blobe, G.C., 2005. Role of transforming growth factor \u03b2 in human cancer. J. Clin. Oncol., 23(9):2078\u20132093. [doi:10.1200\/JCO.2005.02.047]","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"3028_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gde.2008.01.004","volume":"18","author":"J.A. Engelman","year":"2008","unstructured":"Engelman, J.A., Settleman, J., 2008. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev., 18(1):73\u201379. [doi:10.1016\/j.gde.2008.01.004]","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"9","key":"3028_CR8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.leu.2403069","volume":"17","author":"S.J. Kim","year":"2003","unstructured":"Kim, S.J., Letterio, J., 2003. Transforming growth factor-\u03b2 signaling in normal and malignant hematopoiesis. Leukemia, 17(9):1731\u20131737. [doi:10.1038\/sj.leu.2403069]","journal-title":"Leukemia"},{"issue":"12","key":"3028_CR9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/aps.2009.167","volume":"30","author":"Y. Liang","year":"2009","unstructured":"Liang, Y., Xu, R.Z., Zhang, L., Zhao, X.Y., 2009. Berbamine, a novel nuclear factor \u03baB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Acta Pharmacol. Sin., 30(12):1659\u20131665. [doi:10.1038\/aps.2009.167]","journal-title":"Acta Pharmacol. Sin."},{"issue":"24","key":"3028_CR10","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/sj.onc.1207777","volume":"23","author":"K. Mitani","year":"2004","unstructured":"Mitani, K., 2004. Molecular mechanisms of leukemogenesis by AML1\/EVI-1. Oncogene, 23(24):4263\u20134269. [doi:10. 1038\/sj.onc.1207777]","journal-title":"Oncogene"},{"issue":"1","key":"3028_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2169\/internalmedicine1962.28.67","volume":"28","author":"M. Ozaki","year":"1989","unstructured":"Ozaki, M., Kanemitsu, N., Yasukawa, M., Fujita, S., 1989. Basophilic crisis of chronic myelogenous leukemia. Jpn J. Med., 28(1):67\u201371.","journal-title":"Jpn J. Med."},{"issue":"1","key":"3028_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jcp.20304","volume":"204","author":"K. Pardali","year":"2005","unstructured":"Pardali, K., Kowanetz, M., Heldin, C.H., Moustakas, A., 2005. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1\/Cip1). J. Cell. Physiol., 204(1):260\u2013272. [doi:10.1002\/jcp.20304]","journal-title":"J. Cell. Physiol."},{"key":"3028_CR13","first-page":"PE1","volume":"44","author":"B.W.M. Richter","year":"2000","unstructured":"Richter, B.W.M., Duckett, C.S., 2000. The IAP proteins: caspase inhibitors and beyond. Sci. STKE, 44:PE1. [doi:10.1126\/stke.2000.44.pe1]","journal-title":"Sci. STKE"},{"issue":"4","key":"3028_CR14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.leu.2401384","volume":"13","author":"H.M. Rooke","year":"1999","unstructured":"Rooke, H.M., Vitas, M.R., Crosier, P.S., Crosier, K.E., 1999. The TGF-\u03b2 type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression. Leukemia, 13(4):535\u2013541. [doi:10.1038\/sj.leu.2401384]","journal-title":"Leukemia"},{"issue":"37","key":"3028_CR15","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1038\/sj.onc.1208921","volume":"24","author":"F.W. Ruscetti","year":"2005","unstructured":"Ruscetti, F.W., Akel, S., Bartelmez, S.H., 2005. Autocrine transforming growth factor-\u03b2 regulation of hematopoiesis: many outcomes that depend on the context. Oncogene, 24(37):5751\u20135763. [doi:10.1038\/sj.onc.1208921]","journal-title":"Oncogene"},{"issue":"11","key":"3028_CR16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","volume":"29","author":"M. Steinberg","year":"2007","unstructured":"Steinberg, M., 2007. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Clin. Ther., 29(11):2289\u20132308. [doi:10.1016\/j. clinthera.2007.11.005]","journal-title":"Clin. Ther."},{"issue":"4","key":"3028_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/aps.2009.19","volume":"30","author":"Y.L. Wei","year":"2009","unstructured":"Wei, Y.L., Xu, L., Liang, Y., Xu, X.H., Zhao, X.Y., 2009a. Berbanine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacol. Sin., 30(4):451\u2013457. [doi:10.1038\/aps.2009.19]","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"3028_CR18","first-page":"387","volume":"38","author":"Y.L. Wei","year":"2009","unstructured":"Wei, Y.L., Xu, L., Zhao, X.Y., 2009b. Mechanism related to inhibition of leukemia K562 cells by berbamine. J. Zhejiang Univ. (Med. Sci.), 38(4):387\u2013391 (in Chinese).","journal-title":"J. Zhejiang Univ. (Med. Sci.)"},{"issue":"6","key":"3028_CR19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031197","volume":"351","author":"L.A. Wolfraim","year":"2004","unstructured":"Wolfraim, L.A., Fernandez, T.M., Mamura, M., Fuller, W.L., Kumar, R., Cole, D.E., 2004. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N. Engl. J. Med., 351(6): 552\u2013559. [doi:10.1056\/NEJMoa031197]","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"3028_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2005.05.023","volume":"30","author":"R.Z. Xu","year":"2006","unstructured":"Xu, R.Z., Dong, Q.H., Yu, Y.Z., Zhao, X.Y., Gan, X.X., Wu, D., Lu, Q.H., Xu, X.H., Yu, X.F., 2006. Berbanine: a novel inhibitor of bcr\/abl fusion gene with potent anti-leukemia activity. Leuk. Res., 30(1):17\u201323. [doi:10. 1016\/j.leukres.2005.05.023]","journal-title":"Leuk. Res."},{"issue":"1","key":"3028_CR21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1074\/jbc.M104170200","volume":"277","author":"K. Yagi","year":"2002","unstructured":"Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., Mitsuyasu Kato, M., 2002. C-Myc is a downstream target of the Smad pathway. J. Biol. Chem., 277(1):854\u2013861. [doi:10.1074\/jbc.M104170200]","journal-title":"J. Biol. Chem."},{"issue":"4","key":"3028_CR22","first-page":"428","volume":"19","author":"L. Zhang","year":"2003","unstructured":"Zhang, L., Sun, Z., Shen, A.L., Ma, L., Jiang, X.Y., Ma, G.J., 2003. The effects of the Smad3-knockout on the hematopoiesis of mouse. Chin. J. Biotechnol., 19(4):428\u2013432 (in Chinese).","journal-title":"Chin. J. Biotechnol."},{"issue":"6","key":"3028_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/mcbr.2001.0301","volume":"4","author":"H.J. Zhu","year":"2001","unstructured":"Zhu, H.J., Burgess, A.W., 2001. Regulation of transforming growth factor-\u03b2 signaling. Mol. Cell Biol. Res. Commun., 4(6):321\u2013330. [doi:10.1006\/mcbr.2001.0301]","journal-title":"Mol. Cell Biol. Res. Commun."}],"container-title":["Journal of Zhejiang University SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1000230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1000230\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1000230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:18:49Z","timestamp":1572970729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1000230","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}